---
book: Adult HIV
title: Contents
layout: toc
---

# Contents

*	[Acknowledgements](0-4-acknowledgements.html)
*   [Introduction](0-5-introduction.html)
    *   [About the Bettercare series](0-5-introduction.html#about-the-bettercare-series)
    *   [Why decentralised learning?](0-5-introduction.html#why-decentralised-learning)
    *   [Bettercare Online Learning Station](0-5-introduction.html#bettercare-online-learning-station)   
    *   [Books in the Bettercare series](0-5-introduction.html#books-in-the-bettercare-series)
    *   [Format of the courses](0-5-introduction.html#format-of-the-courses)
    *   [Contributors](0-5-introduction.html#contributors)
    *   [Updating the course material](0-5-introduction.html#updating-the-course-material)
    *   [Contact information](0-5-introduction.html#contact-information)
    *   [Registration](0-5-introduction.html#registration)   
{:.prelims}

*	[1. HIV infection](1.html)
	*   [Introduction to HIV infection](1.html#introduction-to-hiv-infection)
	*   [The spread of HIV](1.html#the-spread-of-hiv)
	*   [Screening for HIV infection](1.html#screening-for-hiv-infection)
	*   [Clinical presentation of HIV infection](1.html#clinical-presentation-of-hiv-infection)
	*   [Clinical stages of HIV infection](1.html#clinical-stages-of-hiv-infection)
	*   [Common complications of HIV infection](1.html#common-complications-of-hiv-infection)
	*   [WHO staging system for HIV infection in adults and adolescents](1.html#who-staging-system-for-hiv-infection-in-adults-and-adolescents)
	*   [Case studies](1.html#case-study-1)
*	[2. Managing people with HIV infection](2.html)
	*   [Objectives](2.html#objectives)
	*   [General management](2.html#general-management)
	*   [The role of the community](2.html#the-role-of-the-community)
	*   [Counselling](2.html#counselling)
	*   [Monitoring immune function](2.html#monitoring-immune-function)
	*   [Palliative and terminal care](2.html#palliative-and-terminal-care)
	*   [Case studies](2.html#case-study-1)
*	[3. Preparation for antiretroviral treatment](3.html)
    *   [Objectives](3.html#objectives)
    *   [Indication for antiretroviral treatment](3.html#indication-for-antiretroviral-treatment)
    *   [Referral for anti­retroviral treatment](3.html#referral-for-antiretroviral-treatment)
    *   [Problems with starting antiretroviral treatment](3.html#problems-with-starting-antiretroviral-treatment)
    *   [Preparing for anti­retroviral treatment](3.html#preparing-for-antiretroviral-treatment)
    *   [Screening visits](3.html#screening-visits)
    *   [Case studies](3.html#case-study-1)
*	[4. Antiretroviral drugs](4.html)
    *   [Objectives](4.html#objectives)
    *   [Introduction to anti­retroviral treatment](4.html#introduction-to-antiretroviral-treatment)
    *   [Classes of antiretroviral drugs](4.html#classes-of-antiretroviral-drugs)
    *   [Standardised regimens for antiretroviral treatment](4.html#standardised-regimens-for-antiretroviral-treatment)
    *   [Antiretroviral medication](4.html#antiretroviral-medication)
    *   [Side effects of antiretroviral drugs](4.html#side-effects-of-antiretroviral-drugs)
    *   [Case studies](4.html#case-study-1)
*	[5. Management of patients on antiretroviral treatment](5.html)
    *   [Objectives](5.html#objectives)
    *   [Starting antiretroviral treatment](5.html#starting-antiretroviral-treatment)
    *   [Follow-up visits](5.html#follow-up-visits)
    *   [Monitoring the response to anti­retroviral treatment](5.html#monitoring-the-response-to-antiretroviral-treatment)
    *   [Problems with anti­retroviral treatment](5.html#problems-with-antiretroviral-treatment)
    *   [Adherence](5.html#adherence)
    *   [Drug resistance](5.html#drug-resistance)
    *   [Treatment failure](5.html#treatment-failure)
    *   [Drug interactions](5.html#drug-interactions)
    *   [Drug interruptions](5.html#drug-interruptions)
    *   [Side effects of antiretroviral agents](5.html#side-effects-of-antiretroviral-agents)
    *   [Immune Reconstitution Inflammatory Syndrome (IRIS)](5.html#immune-reconstitution-inflammatory-syndrome-iris)
    *   [Quality of life](5.html#quality-of-life)
    *   [Expense](5.html#expense)
    *   [Case studies](5.html#case-study-1)
*	[6. HIV-associated infections](6.html)
    *   [Objectives](6.html#objectives)
    *   [Common HIV-associated infections](6.html#common-hiv-associated-infections)
    *   [Pneumocystis pneumonia](6.html#pneumocystis-pneumonia)
    *   [Infections of the central nervous system](6.html#infections-of-the-central-nervous-system)
    *   [Tuberculosis co-infection](6.html#tuberculosis-co-infection)
    *   [Case studies](6.html#case-study-1)
*	{:.auxiliary}[6a. Skills: Screening tests for HIV](6a.html)
	*   [Equipment needed to perform an HIV rapid test](6a.html#a-equipment-needed-to-perform-an-hiv-rapid-test)
	*   [The method of performing the HIV rapid test](6a.html#b-the-method-of-performing-the-hiv-rapid-test)
	*   [Reading the results of the HIV rapid test](6a.html#c-reading-the-results-of-the-hiv-rapid-test)
	*   [The interpretation of the HIV rapid test](6a.html#d-the-interpretation-of-the-hiv-rapid-test)
	*   [Management if the HIV rapid test is positive](6a.html#e-management-if-the-hiv-rapid-test-is-positive)
	*   [Management if the first HIV rapid test is positive but the second is negative](6a.html#f-management-if-the-first-hiv-rapid-test-is-positive-but-the-second-is-negative)

## Tests

*	[1. HIV infection](test-1.html)
*	[2. Managing people with HIV infection](test-2.html)
*	[3. Preparation for antiretroviral treatment](test-3.html)
*	[4. Antiretroviral drugs](test-4.html)
*	[5. Management of patients on antiretroviral treatment](test-5.html)
*	[6. HIV-associated infections](test-6.html)

*	[Answers](test-answers.html)	
